Lincomycin by direct intravitreal injection in the treatment of experimental bacterial endophthalmitis.
D000038:Abscess / Q000209:etiology / Q000473:pathology; D000818:Animals; D004195:Disease Models, Animal; D005123:Eye / Q000473:pathology; D005128:Eye Diseases / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D007267:Injections / Q000379:methods; D008034:Lincomycin / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity; D008657:Metabolic Clearance Rate; D010202:Panophthalmitis / Q000209:etiology / Q000473:pathology; D011817:Rabbits; D012160:Retina / Q000473:pathology; D012164:Retinal Diseases / Q000139:chemically induced / Q000473:pathology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D013997:Time Factors; D014822:Vitreous Body / Q000378:metabolism
D008034:Lincomycin